Lymphoproliferation and cytokine profiles in human peripheral blood mononuclear cells stimulated by Cryptococcus neoformans

Journal of Medical and Veterinary Mycology

Volumn 35, Issue 4, 1997, Pages 229-236

  Levitz, S M ^a   North, E A ^a  

^a BOSTON MEDICAL CENTER   (United States)

Author keywords

C. neoformans; Human PBMC; Profiles

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2;

ARTICLE; CONTROLLED STUDY; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNOREACTIVITY; INFECTION RESISTANCE; LYMPHOCYTE PROLIFERATION; MONONUCLEAR CELL; NORMAL HUMAN; PROTEIN SECRETION;

CANDIDA ALBICANS; FILOBASIDIELLA NEOFORMANS;

EID: 80051523661     PISSN: 02681218     EISSN: None     Source Type: Journal    
DOI: 10.1080/02681219780001201     Document Type: Article

References (34)

1. Romagnani S. Human TH1 and TH2 subsets: 'eppur si muove!'. Eur Cytokine Network 1994; 5: 7-12.
2. Salgame P, Abrams JS, Clayberger C, et al. Differing lymphokine profiles of functional subsets of human CD4 and CDS T cell clones. Science 1991; 254: 279-82.
3. Yamamura M, Uyemura K, Deans RJ, et al. Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science 1991; 254: 277-9
4. Hoy JF, Murphy JW, Miller GG. T cell response to soluble cryptococcal antigens after recovery from cryptococcal infection. J Infect Dis 1989; 159: 116-19.
5. Levitz SM, Farrell TP, Maziarz RT. Killing of Cryptococcus neoformans by human peripheral blood mononuclear cells stimulated in culture. J Infect Dis 1991; 163: 1108-13.
6. Miller GPG, Puck J. In vitro human lymphocyte responses to Cryptococcus neoformans. Evidence for primary and secondary responses in normals and infected subjects. J Immunol 1984; 133: 166-72.
7. Levitz SM. The ecology of Cryptococcus neoformans and the epidemiology of cryptococcosis. Rev Inject Dis 1991; 13: 1163-9.
8. Levitz SM, North EA. Gamma interferon gene expression and release in human lymphocytes directly activated by Cryptococcus neoformans and Candida albicans. Infect Immun 1966; 64: 1595-9.
9. Levitz SM, Tabuni A, Kornfeld H, Reardon CC, Golenbock DT. Production of tumor necrosis factor-alpha in human leukocytes stimulated by Crvptococcus neoformans. Infect Immun 1994; 62: 1975-81.
10. Levitz SM, Dupont MP, Smail EH. Direct activity of human T lymphocytes and natural killer cells against Crvptococcus neoformans. Infect Immun 1994; 62: 194-202.
11. Miller MF, Mitchell TG, Storkus WJ, Dawson JR. Human natural killer cells do not inhibit growth of Cryptococcus neoformans in the absence of antibody. Infect Immun 1990; 58: 639-45.
12. Levitz SM, Lyman CA, Murata T, et al. Cytosolic calcium changes in individual neutrophils stimulated by opsonized and unopsonized Candida albicans hyphae. Infect Immun 1987; 55: 2783-8.
13. Treseler CB, Maziarz RT, Levitz SM. Biological activity of interleukin-2 bound to Candida albicans. Infect Immun 1992; 60: 183-8.
14. Murphy JW, Mosley RL, Cherniak R, et al. Serological, electrophoretic. and biological properties of Cryptococcus neoformans antigens. Infect Immun 1988; 56: 424-31.
15. Turner SH, Cherniak R, Reiss E. Fractionation and characterization of galactoxylomannan from Cryptococcus neoformans. Carbohydrate Res 1984; 125: 343-9.
16. Levitz SM, Tabuni A. Binding of Cryptococcus neoformans by human cultured macrophages. Requirements for multiple complement receptors and actin. J Clin Invest 1991; 87: 528-35.
17. Ausiello CM, Spagnoli GC, Boccanera M, et al. Proliferation of human peripheral blood mononuclear cells induced by Candida albicans and its cell wall fractions. J Med Microbiol 1986; 22: 195-202.
18. Fung PYS, Murphy JW. In vitro interactions of immune lymphocytes and Crvptococcus neoformans. Infect Immun 1982; 36: 1128-38.
19. Lim TS, Murphy JW. Transfer of immunity to cryptococcosis by T-enriched splenic lymphocytes from Cryptococcus neoformans-sensitized mice. Infect Immun 1980; 30: 5-11.
20. Murphy JW. Influence of cryptococcal antigens on cell-mediated immunity. Rev Infect Dis 1988: 10 (Suppl. 2): S432-S435.
21. Murphy JW. Cytokine profiles associated with induction of the anticryptococcal cell-mediated immune response. Infect Immun 1993; 61: 4750-9.
22. Vecchiarelli A, Pietrella D, Dottorini M, et al. Encapsulation of Cryptococcus neoformans regulates fungicidal activity and the antigen presentation process in human alveolar macrophages. Clin Exp Immunol 1994; 98: 217-23.
23. Romani L, Cenci E, Menacci A, Bistoni F, Puccetti P. T helper cell dichotomy to Candida albicans: implications for pathology, therapy, and vaccine design. Immunol Res 1995; 14: 148-62.
24. Cenci E, Mencacci A, Spaccapelo R, et al. T helper cell type 1 (Th1)- and Th2-like responses are present in mice with gastric candidiasis but protective immunity is associated with Th1 development. J Infect Dis 1995; 171: 1279-88.
25. Fidel PL Jr, Lynch ME, Sobel JD. Effects of preinduced Candida-specific systemic cell-mediated immunity on experimental vaginal candidiasis. Infect Immun 1994; 62: 1032-8.
26. Romani L, Mocci S, Bietta C, et al. Th1 and Th2 cytokine secretion patterns in murine candidiasis: association of Th1 responses with acquired resistance. Infect Immun 1991; 59: 4647-54.
27. Tonnetti L, Spaccapelo R, Cenci E, et al. Interleukin-4 and -10 exacerbate candidiasis in mice. Eur J Immunol 1995; 25: 1559-65.
28. Hoy JF, Lewis DE, Miller GG. Functional versus phenotypic analysis of T cells in subjects seropositive for the human immunodeficiency virus: A prospective study of in vitro responses to Cryptococcus neoformans. J Infect Dis 1988; 158: 1071-8.
29. + T-lymphocytopenia - Four patients with opportunistic infections and no evidence of HIV infection. N EngI J Med 1993; 328: 393-8.
30. Levitz SM, Mathews HL, Murphy JW. Direct antimicrobial activity of T cells. Immunol Today 1995; 16: 387-91.
31. Levitz SM, Tabuni A, Nong S-H, Golenbock DT. Effects of interleukin-10 on human peripheral blood mononuclear cell responses to Cryptococcus neoformans, Candida albicans, and lipopolysaccharide. Infect Immun 1996; 64: 945-51.
32. Collins HL, Bancroft GJ. Encapsulation of Cryptococcus neoformans impairs antigen-specific T-cell responses. Infect Immun 1991; 59: 3883-8.
33. Mody CH, Syme RM. Effect of polysaccharide capsule and methods of preparation on human lymphocyte proliferation in response to Cryptococcus neoformans. Infect Immun 1993; 61: 464-9.
34. Newberry WM Jr, Walter JE, Chandler JW Jr, Tosh FE. Epidemiologic study of Cryptococcus neoformans. Ann Intern Med 1967; 67: 724-32.